CEO. OPERATOR. AUTHOR.

I'd rather give you a hard truth than a soft lie.

I help MedTech companies close the gap between a product that works and a business that grows. Two decades in the field. No sugarcoating.

Start the conversation
CLARITY OVER COMFORT. ALWAYS.
Matt Tucker in a blue blazer, standing outside a historic building
MATT TUCKERCEO, NIGHTWARE
20+Years in healthcare
6Products launched
3Acquisitions integrated
$1B+Portfolio P&L led
EXPERIENCE BUILT AT
BaxterHighmark HealthmylanNightWare.

EXPERIENCE. NOT THEORY.

Startups to multinationals.
And back.

Pittsburgh. Father of four.
At home on the water and on skis.

My first launch, I didn't really know what I was doing. Thirty brands later, I know what separates a good clinical story from a real commercial business.

I've launched drugs, devices, combination products and software. I've integrated a $275M acquisition, rehabilitated a $1B brand, and worked on both the founding and funding sides of the table.

Today, I'm CEO and Board Director of NightWare and President of Breakthrough MedTech Strategy. I take the commercial seat, not the sidelines.

MBA, Global Finance · B.S., Chemistry
Butler University
Leadership in Healthcare Award, 2022
Health 2.0 Conference · PM360 Brand Trailblazer
01.

Clarity over comfort.

Say it while it's still a problem to solve, not a verdict to deliver.

02.

Experience beats theory.

Real launches. Real customers. Lessons learned carrying the bag.

03.

Look six years ahead.

Position for what the market will reward next. Execute today.

CURRENTLY / LEADING NIGHTWARE

A real company.
A mission that matters.

NightWare is an FDA-cleared prescription digital therapeutic for PTSD-related nightmares. I built its commercial function from $0 to $7.5M, with Department of Defense adoption along the way. In June 2024, I became CEO to lead a strategic and financial reset.

Visit NightWare

BREAKTHROUGH MEDTECH STRATEGY

Good science isn't
a commercial strategy.

The gap between “this works” and “hospitals pay for this, repeatedly” is where good companies get stuck. Closing that gap is what I do.

01BEFORE LAUNCHCommercialization planning

Build the commercial foundation before you build the sales team. Customer insight, clinical utility, evidence, brand and a focused strategy your team can actually execute.

Customer & market insight · Evidence planning · Launch strategyTalk about your launch
02IN MARKETFractional commercial leadership

I take the seat, not the sidelines. Sales design and compensation, contracting, marketing, payer access and enablement—until you know exactly what full-time hire you need.

Sales build-out · Payer access · Commercial executionTalk about your growth
03THE NEXT CHAPTERPositioning for acquisition

Build a commercial story that survives diligence. I've integrated acquisitions from the buy side and advised ten premarket products, including a client exit to Integra LifeSciences.

Commercial narrative · Buyer readiness · Strategic positioningTalk about your next move

FOR BOARDS, INVESTORS & CEOS

The diagnosis in sixty days.

An independent operator's view of where the commercial plan is breaking. Scoped around a decision, not a calendar.

Get an operator's view

SELECTED OUTCOMES

$61M → $111MSurgical hemostasis brand
in 18 months
$0 → $7.5MNightWare commercial build
with DoD adoption
$150K → $1.1MHighmark's VITAL program
in one year

REAL EXPERIENCE. ON THE PAGE.

The hard conversations.
Now on the page.

No theory. Real board meetings, real numbers, and the questions that matter when the plan isn't working.

2026 / FOR BOARDS, INVESTORS & CEOS

Nobody Wants to Say It.

What MedTech boards and investors see, don't say, and pay for later.

I wrote it for the person who wrote the check, and for the CEO who knows the plan isn't working. It's the operator's view of governance under stress—and a way to raise the hard question without losing the CEO.

  • Read the company, not just the board deck.
  • Recognize commercial drift before it becomes a verdict.
  • Put each chapter's board diagnostic to work at your next meeting.

The fastest way to find out whether the way I think is useful to you.

READ FIRST. DECIDE FOR YOURSELF.

Nobody Wants to Say It. Your free ebook.

Practical board diagnostics and an operator's perspective on the conversations that can't wait.

KEYNOTES. PANELS. REAL CONVERSATIONS.

I say the thing
nobody wants to say.
With numbers.

No buzzwords. No hype. Real launches, real board meetings, and frameworks your audience can run on Monday morning.

MedTech commercialization

The Ten MedTech Commandments: what decides whether a product gets adopted or shelved.

Governance under pressure

Nobody Wants to Say It: how boards raise hard questions without losing the CEO.

A career on your own terms

The Selfish Career: goals, leverage, and skills that outlast any employer.

Tell me about your event
Matt Tucker, seated at right, participating in a veterans, PTSD and recovery panel
ON STAGE / THE HERO'S JOURNEYJohn P. Mayhugh Foundation
Veterans, PTSD & recovery
Keynotes30–60 minutes + Q&A
PanelsModerator or panelist
WorkshopsHalf-day, applied
Board offsitesClosed-door diagnostics

SPECIFIC QUESTIONS. HONEST ANSWERS.

Tell me what's
not working.

Consulting, NightWare, books or speaking. Give me enough detail for a real answer instead of a “tell me more.”

[email protected]
Connect on LinkedIn PITTSBURGH, PENNSYLVANIA
“A hard truth beats a soft lie.”— MATT TUCKER
START THE CONVERSATION

Opens a draft in your email app. Nothing is sent or stored by this page. Prefer to write directly? Email Matt.

NOBODY WANTS TO SAY IT / FREE EBOOK

Read first.
Decide for yourself.

Request your free copy of Nobody Wants to Say It.

This opens an email draft to Matt. Send it from your email app to request Nobody Wants to Say It; this page does not send ebooks automatically.